Exact Mass: 606.3168826

Exact Mass Matches: 606.3168826

Found 289 metabolites which its exact mass value is equals to given mass value 606.3168826, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cepharanthine

(14S,27R)-22,33-dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.2(16,19).1(3,10).1(21,25).0(4,8).0(14,39).0(31,35)]nonatriaconta-1(33),3,8,10(39),16,18,21(36),22,24,31,34,37-dodecaene

C37H38N2O6 (606.2729727999999)

Cepharanthine is a bisbenzylisoquinoline alkaloid from tubers of Stephania; stimulates recovery of immunologic function in lymphatic system after administration of antineoplastic agents or x-irradiation. It is a member of isoquinolines and a bisbenzylisoquinoline alkaloid. Cepharanthine is a natural product found in Stephania sinica, Stephania cephalantha, and other organisms with data available. A bisbenzylisoquinoline alkaloid from tubers of Stephania; stimulates recovery of immunologic function in lymphatic system after administration of antineoplastic agents or x-irradiation. C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D020011 - Protective Agents > D011837 - Radiation-Protective Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D000970 - Antineoplastic Agents D018501 - Antirheumatic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Origin: Plant; SubCategory_DNP: Isoquinoline alkaloids, Benzylisoquinoline alkaloids Cepharanthine is a natural product that can be isolated from the plant Stephania?cephalantha?Hayata. Cepharanthine has anti-severe acute respiratory syndrome coronavirus 2 (anti-SARS-CoV-2) activities. Cepharanthine has good effective in suppressing viral proliferation (half maximal (50\\%) inhibitory concentration (IC50) and 90\\% inhibitory concentration (IC90) values of 1.90 and 4.46?μM[1]. Cepharanthine can also effectively reverses P-gp-mediated multidrug resistance in K562 cells and increase enhances the sensitivity of anticancer agents in xenograft mice model[2][3]. Cepharanthine shows inhibitory effects of human liver cytochrome P450 enzymes CYP3A4, CYP2E1 and CYP2C9. Cepharanthine has antitumor, anti-inflammatory and antinociceptive effects[4][5][6][7][8]. Cepharanthine is a natural product that can be isolated from the plant Stephania?cephalantha?Hayata. Cepharanthine has anti-severe acute respiratory syndrome coronavirus 2 (anti-SARS-CoV-2) activities. Cepharanthine has good effective in suppressing viral proliferation (half maximal (50\%) inhibitory concentration (IC50) and 90\% inhibitory concentration (IC90) values of 1.90 and 4.46?μM[1]. Cepharanthine can also effectively reverses P-gp-mediated multidrug resistance in K562 cells and increase enhances the sensitivity of anticancer agents in xenograft mice model[2][3]. Cepharanthine shows inhibitory effects of human liver cytochrome P450 enzymes CYP3A4, CYP2E1 and CYP2C9. Cepharanthine has antitumor, anti-inflammatory and antinociceptive effects[4][5][6][7][8].

Clerodendrin A

C31H42O12 (606.2676132)

Fulvestrant

(1S,9R,11S,14S,15S)-15-methyl-9-[9-(4,4,5,5,5-pentafluoropentanesulfinyl)nonyl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-triene-5,14-diol

C32H47F5O3S (606.3165892)

Fulvestrant is a drug treatment of hormone receptor-positive metastatic breast cancer in post-menopausal women with disease progression following anti-estrogen therapy. It is an estrogen receptor antagonist with no agonist effects, which works both by down-regulating and by degrading the estrogen receptor. L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BA - Anti-estrogens D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2116 - Selective Estrogen Receptor Down Regulator C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist D000970 - Antineoplastic Agents

(23S)-23,25-dihdroxy-24-oxovitamine D3 23-(beta-glucuronide)

(2S,3S,4S,5R)-6-{[(4S,6R)-6-[(1R,3aS,4E,7aR)-4-{2-[(1Z,5S)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene}-7a-methyl-octahydro-1H-inden-1-yl]-2-hydroxy-2-methyl-3-oxoheptan-4-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C33H50O10 (606.34038)

(23S)-23,25-dihdroxy-24-oxovitamine D3 23-(beta-glucuronide) is a natural human metabolite of (23S)-23,25-dihdroxy-24-oxovitamine D3 generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys.

Cepharanthine

22,33-dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.2¹⁶,¹⁹.1³,¹⁰.1²¹,²⁵.0⁴,⁸.0³¹,³⁵.0¹⁴,³⁹]nonatriaconta-1(33),3(39),4(8),9,16,18,21,23,25(36),31,34,37-dodecaene

C37H38N2O6 (606.2729727999999)

13-Methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol

13-Methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol

C32H47F5O3S (606.3165892)

N,N-Diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine

2-[(2-{[2-({2-[bis(prop-2-en-1-yl)amino]-1-hydroxy-3-(4-hydroxyphenyl)propylidene}amino)-1-hydroxy-2-methylpropylidene]amino}-1-hydroxy-3-phenylpropylidene)amino]-4-methylpentanoate

C34H46N4O6 (606.3417176)

PA(8:0/5-iso PGF2VI)

[(2R)-2-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}-3-(octanoyloxy)propoxy]phosphonic acid

C29H51O11P (606.3168826)

PA(8:0/5-iso PGF2VI) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/5-iso PGF2VI), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of 5-iso Prostaglandin F2alpha-VI at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(5-iso PGF2VI/8:0)

[(2R)-3-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}-2-(octanoyloxy)propoxy]phosphonic acid

C29H51O11P (606.3168826)

PA(5-iso PGF2VI/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(5-iso PGF2VI/8:0), in particular, consists of one chain of one 5-iso Prostaglandin F2alpha-VI at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Scortechinone G

C35H42O9 (606.2828682)

Caseobliquin B

C35H42O9 (606.2828682)

Methylwarifteine

O-Methylwarifteine

C37H38N2O6 (606.2729727999999)

N-Methyltiliamosine

C37H38N2O6 (606.2729727999999)

Caucasicoside A

(1S,4S,8S,9S,11R,13R,14R,16R)-7,9,13-trimethyl-6-[3-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]but-3-enyl]-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-6,18-diene-11,14,16-triol

C33H50O10 (606.34038)

Methyl phaeophorbide

Methyl pheophorbide a

C36H38N4O5 (606.2842058)

Methyl pheophorbide a is practically insoluble (in water) and an extremely strong acidic compound (based on its pKa). Methyl pheophorbide a can be found in japanese persimmon, which makes methyl pheophorbide a a potential biomarker for the consumption of this food product.

O,O-Dimethylcocsulinine

(+)-O,O-Dimethylcocsulinine

C37H38N2O6 (606.2729727999999)

Taxinine

C35H42O9 (606.2828682)

1-deacetylkhivorin

C35H42O9 (606.2828682)

Pheophorbide a methyl ester

13-epi-Phaeophorbide a methyl ester

C36H38N4O5 (606.2842058)

[(1R,3R,5S,7S,8S,9R,10R)-7,9,10-triacetyloxy-8,12,15,15-tetramethyl-4-methylidene-13-oxo-5-tricyclo[9.3.1.0^{3,8]pentadec-11-enyl] (E)-3-phenylprop-2-enoate

C35H42O9 (606.2828682)

Medelline

C37H38N2O6 (606.2729727999999)

physaloside A

C29H50O13 (606.3251250000001)

2alpha,4alpha,7beta,9alpha,1alpha,15-hexahydroxy-5alpha,20-diacetoxy-10beta-benzoxy-11(15->1)abeotaxa-11-ene|taxuyunnanine U

C31H42O12 (606.2676132)

2beta-Acetoxy-6beta-cinnamoyloxyisozuelanin

C35H42O9 (606.2828682)

Euphorbia factor Ti7

C36H46O8 (606.3192516)

schizonellin B

C30H54O12 (606.3615084)

(-)-medelline|medelline

C37H38N2O6 (606.2729727999999)

Dibenzoylgagaimol

C35H42O9 (606.2828682)

6-hydroxy-16alpha-acetoxycalactin

C31H42O12 (606.2676132)

C36H46O8

C36H46O8 (606.3192516)

C30H54O12

C30H54O12 (606.3615084)

propindilactone L

C31H42O12 (606.2676132)

A natural product found in Schisandra propinqua.

glaucacetalin B

C33H50O10 (606.34038)

Arenastatin A|cryptophycin 24|cryptophycin-24

C34H42N2O8 (606.2941012)

C33H50O10

C33H50O10 (606.34038)

Thapsivillosin I

C31H42O12 (606.2676132)

3beta-(beta-glucopyranosyloxyuronic acid)-16-hydroxy-5alpha,14beta-cholest-16-ene-15,23-dione|pandaroside D

C33H50O10 (606.34038)

2alpha,3beta-dihydroxy-spirost-5,25(27)-diene-1beta-yl O-beta-D-galactopyranoside|atropuroside D

C33H50O10 (606.34038)

NSC104945

C37H38N2O6 (606.2729727999999)

anthogorgiene M

C44H46O2 (606.3497616)

cochinchinoid C

C36H46O8 (606.3192516)

3beta,5alpha,8alpha,15beta-tetraacetoxy-7beta-propionyloxyjatropha-6(17),11E-diene-4,14-dione

C31H42O12 (606.2676132)

brialalepolide C

C32H46O11 (606.3039966)

A natural product found in Briareum species.

6,12-dimethoxy-2,2-dimethyl-6,8alpha-(1-oxa-ethane-1,2-diyl)-8H-berbaman-7-one|Pseudorepandulin|pseudorepanduline

C37H38N2O6 (606.2729727999999)

26-O-beta-D-glucopyranosyl-(25R)-furostan-4-ene-22alpha,26-diol-3,12-dione|Terrestrinone A1

C33H50O10 (606.34038)

12-O-(6-O-acetyl-beta-D-glucopyranosyl-(1?2)-beta-D-glucopyranosyl)-campherenane-2-endo,12-diol

C29H50O13 (606.3251250000001)

walsucochinoid R

C36H46O8 (606.3192516)

Elansolid B1

C37H50O7 (606.355635)

iriomoteolide-13a

C33H50O10 (606.34038)

ajugacumbin E

C31H42O12 (606.2676132)

Ocotosine

C37H38N2O6 (606.2729727999999)

C32H46O11

C32H46O11 (606.3039966)

(1S,4R,5S,6R,7R,8R,9S,10S)-6-acetoxy-1,9-dibenzoyloxy-8-butyryloxydihydro-beta-agarofuran

C35H42O9 (606.2828682)

5alpha-cinnamoyloxy-2alpha,10beta,13alpha-triacetoxy-2(3->2)abeo-taxa-4(20),11-dien-9-one

C35H42O9 (606.2828682)

1beta,24beta-dihydroxy-spirost-5,25(27)-dien-3alpha-yl O-beta-D-glucopyranoside|tupistroside B

C33H50O10 (606.34038)

atrata-phloroglucinol B

C36H46O8 (606.3192516)

O1-Deacetyl-O7-detigloyl-O7-benzoylnimbolinin B

C35H42O9 (606.2828682)

1alpha,2alpha-di-(alpha-methyl)-butanoyloxy-4beta-hydroxy-9beta-(beta-)furoyloxy-15-acetoxy-beta-dihydroagarofuran|1??,2??-Di-(a-methyl)-butanoyl-4??-hydroxy-9??-(??-)furoyloxy-15-acetoxy-??-dihydroagarofuran

1alpha,2alpha-di-(alpha-methyl)-butanoyloxy-4beta-hydroxy-9beta-(beta-)furoyloxy-15-acetoxy-beta-dihydroagarofuran|1??,2??-Di-(a-methyl)-butanoyl-4??-hydroxy-9??-(??-)furoyloxy-15-acetoxy-??-dihydroagarofuran

C32H46O11 (606.3039966)

phorbol 20-trityl|phorbol 20-tritylether|phorbol-20-trityl ether|Phorbol-20-tritylaether

C39H42O6 (606.2981232)

20-hydroxyecdysone 2,3,22-triacetate|20-hydroxyecdysone-2,3,22-triacetate|Ecdysteron-2,3,22-triacetat|Ecdysteron-triacetat-(2,3,22)|ecdysterone 2,3,22-triacetate|ecdysterone 2beta,3beta,22R-triacetate|ecdysterone triacetate

C33H50O10 (606.34038)

(+)-guattamine|Guattamine

C37H38N2O6 (606.2729727999999)

(1R,2S,4S,5S,6R,7R,8S,9S,10S)-1,2-diacetoxy-9-benzoyloxy-15-(2-methylbutyroyloxy)-4,6,8-trihydroxydihydro-beta-agarofuran

C31H42O12 (606.2676132)

racemosidine A

C37H38N2O6 (606.2729727999999)

pre-schisanartanin D

C31H42O12 (606.2676132)

ajugamacrin C

C32H46O11 (606.3039966)

Phe Ala Glu Lys Ile

C29H46N6O8 (606.3376956)

Phe Gln Lys Lys Gly

C28H46N8O7 (606.3489285999999)

Arg Tyr Ile Arg

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylpentanamido]-5-carbamimidamidopentanoic acid

C27H46N10O6 (606.3601616000001)

Thr Lys Met Val Glu

C25H46N6O9S (606.3046826)

Ile Arg Tyr Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-(4-hydroxyphenyl)propanamido]-5-carbamimidamidopentanoic acid

C27H46N10O6 (606.3601616000001)

Glu Cys Glu Val Lys

C24H42N6O10S (606.2682992)

NCI60_003881

methyl 16-ethenyl-11-ethyl-4-hydroxy-22-(3-methoxy-3-oxopropyl)-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaene-3-carboxylate

C36H38N4O5 (606.2842058)

Methyl phaeophorbide is a natural product found in Saussurea medusa with data available.

Taxinin

CINNAMIC ACID, 3-ESTER WITH 1,3,4,4A.ALPHA.,5,6.BETA.,7,11,12,12A-DECAHYDRO-3.ALPHA.,5.ALPHA.,11.BETA.,12.ALPHA.-TETRAHYDROXY-9,12A.BETA.,13,13-TETRAMETHYL-4-METHYLENE-6,10-METHANOBENZOCYCLODECEN-8(2H)-ONE TRIACETATE

C35H42O9 (606.2828682)

Taxinine is a natural product found in Taxus wallichiana, Taxus baccata, and other organisms with data available.

Fulvestrant

7α-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]-estra-1,3,5(10)-triene-3,17β-diol

C32H47F5O3S (606.3165892)

L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BA - Anti-estrogens D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2116 - Selective Estrogen Receptor Down Regulator C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist D000970 - Antineoplastic Agents

2-Deacetoxy taxinine B

C35H42O9 (606.2828682)

C33H50O10_(1beta,3beta,9xi,11alpha,14xi)-1,3,11-Trihydroxyfurosta-5,20(22),25-trien-27-yl beta-D-glucopyranoside

NCGC00384618-01_C33H50O10_(1beta,3beta,9xi,11alpha,14xi)-1,3,11-Trihydroxyfurosta-5,20(22),25-trien-27-yl beta-D-glucopyranoside

C33H50O10 (606.34038)

C32H46O11_Carda-4,20(22)-dienolide, 6-(acetyloxy)-3-[(6-deoxy-3-O-methyl-beta-D-galactopyranosyl)oxy]-8,14-dihydroxy-, (3beta,8xi,9xi)

NCGC00168848-03_C32H46O11_Carda-4,20(22)-dienolide, 6-(acetyloxy)-3-[(6-deoxy-3-O-methyl-beta-D-galactopyranosyl)oxy]-8,14-dihydroxy-, (3beta,8xi,9xi)-

C32H46O11 (606.3039966)

3-O-p-hydroxybenzoyl ceanothic acid

C37H50O7 (606.355635)

Glu Phe Arg Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-phenylpropanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C26H42N10O7 (606.3237782000001)

Glu Arg Phe Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-5-carbamimidamidopentanamido]-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C26H42N10O7 (606.3237782000001)

Glu Arg Arg Phe

(4S)-4-amino-4-{[(1S)-4-carbamimidamido-1-{[(1S)-4-carbamimidamido-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}butyl]carbamoyl}butyl]carbamoyl}butanoic acid

C26H42N10O7 (606.3237782000001)

Phe Glu Arg Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-carboxybutanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C26H42N10O7 (606.3237782000001)

Phe Phe Phe Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanamido]-3-phenylpropanamido]-3-phenylpropanoic acid

C36H38N4O5 (606.2842058)

Phe Arg Glu Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]-4-carboxybutanamido]-5-carbamimidamidopentanoic acid

C26H42N10O7 (606.3237782000001)

Phe Arg Arg Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]pentanedioic acid

C26H42N10O7 (606.3237782000001)

Phe Arg Val Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]-3-methylbutanamido]-3-(1H-indol-3-yl)propanoic acid

C31H42N8O5 (606.3278002)

Phe Arg Trp Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]-3-methylbutanoic acid

C31H42N8O5 (606.3278002)

Phe Val Arg Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanoic acid

C31H42N8O5 (606.3278002)

Phe Val Trp Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanoic acid

C31H42N8O5 (606.3278002)

Phe Trp Arg Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]-3-methylbutanoic acid

C31H42N8O5 (606.3278002)

Phe Trp Val Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-methylbutanamido]-5-carbamimidamidopentanoic acid

C31H42N8O5 (606.3278002)

His His Lys Trp

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]hexanamido]-3-(1H-indol-3-yl)propanoic acid

C29H38N10O5 (606.3026497999999)

His His Trp Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanamido]hexanoic acid

C29H38N10O5 (606.3026497999999)

His Lys His Trp

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C29H38N10O5 (606.3026497999999)

His Lys Trp His

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C29H38N10O5 (606.3026497999999)

His Trp His Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

C29H38N10O5 (606.3026497999999)

His Trp Lys His

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanamido]hexanamido]-3-(1H-imidazol-4-yl)propanoic acid

C29H38N10O5 (606.3026497999999)

Ile Arg Arg Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-(4-hydroxyphenyl)propanoic acid

C27H46N10O6 (606.3601616000001)

Ile Tyr Arg Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(4-hydroxyphenyl)propanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C27H46N10O6 (606.3601616000001)

Lys His His Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C29H38N10O5 (606.3026497999999)

Lys His Trp His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C29H38N10O5 (606.3026497999999)

Lys Trp His His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C29H38N10O5 (606.3026497999999)

Leu Arg Arg Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-(4-hydroxyphenyl)propanoic acid

C27H46N10O6 (606.3601616000001)

Leu Arg Tyr Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-(4-hydroxyphenyl)propanamido]-5-carbamimidamidopentanoic acid

C27H46N10O6 (606.3601616000001)

Leu Tyr Arg Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(4-hydroxyphenyl)propanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C27H46N10O6 (606.3601616000001)

Arg Glu Phe Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-carboxybutanamido]-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C26H42N10O7 (606.3237782000001)

Arg Glu Arg Phe

(4S)-4-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-{[(1S)-4-carbamimidamido-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}butyl]carbamoyl}butanoic acid

C26H42N10O7 (606.3237782000001)

Arg Phe Glu Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]-4-carboxybutanamido]-5-carbamimidamidopentanoic acid

C26H42N10O7 (606.3237782000001)

Arg Phe Arg Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]-5-carbamimidamidopentanamido]pentanedioic acid

C26H42N10O7 (606.3237782000001)

Arg Phe Val Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]-3-methylbutanamido]-3-(1H-indol-3-yl)propanoic acid

C31H42N8O5 (606.3278002)

Arg Phe Trp Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-methylbutanoic acid

C31H42N8O5 (606.3278002)

Arg Ile Arg Tyr

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-(4-hydroxyphenyl)propanoic acid

C27H46N10O6 (606.3601616000001)

Arg Ile Tyr Arg

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-(4-hydroxyphenyl)propanamido]-5-carbamimidamidopentanoic acid

C27H46N10O6 (606.3601616000001)

Arg Leu Arg Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-(4-hydroxyphenyl)propanoic acid

C27H46N10O6 (606.3601616000001)

Arg Leu Tyr Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-(4-hydroxyphenyl)propanamido]-5-carbamimidamidopentanoic acid

C27H46N10O6 (606.3601616000001)

Arg Arg Glu Phe

(4S)-4-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-4-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}butanoic acid

C26H42N10O7 (606.3237782000001)

Arg Arg Phe Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-phenylpropanamido]pentanedioic acid

C26H42N10O7 (606.3237782000001)

Arg Arg Ile Tyr

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-(4-hydroxyphenyl)propanoic acid

C27H46N10O6 (606.3601616000001)

Arg Arg Leu Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-(4-hydroxyphenyl)propanoic acid

C27H46N10O6 (606.3601616000001)

Arg Arg Tyr Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylpentanoic acid

C27H46N10O6 (606.3601616000001)

Arg Arg Tyr Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-(4-hydroxyphenyl)propanamido]-4-methylpentanoic acid

C27H46N10O6 (606.3601616000001)

Arg Val Phe Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C31H42N8O5 (606.3278002)

Arg Val Trp Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanoic acid

C31H42N8O5 (606.3278002)

Arg Trp Phe Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-methylbutanoic acid

C31H42N8O5 (606.3278002)

Arg Trp Val Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]-3-methylbutanamido]-3-phenylpropanoic acid

C31H42N8O5 (606.3278002)

Arg Tyr Leu Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(4-hydroxyphenyl)propanamido]-4-methylpentanamido]-5-carbamimidamidopentanoic acid

C27H46N10O6 (606.3601616000001)

Arg Tyr Arg Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(4-hydroxyphenyl)propanamido]-5-carbamimidamidopentanamido]-3-methylpentanoic acid

C27H46N10O6 (606.3601616000001)

Arg Tyr Arg Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(4-hydroxyphenyl)propanamido]-5-carbamimidamidopentanamido]-4-methylpentanoic acid

C27H46N10O6 (606.3601616000001)

Val Phe Arg Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanoic acid

C31H42N8O5 (606.3278002)

Val Phe Trp Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanoic acid

C31H42N8O5 (606.3278002)

Val Arg Phe Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C31H42N8O5 (606.3278002)

Val Arg Trp Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanoic acid

C31H42N8O5 (606.3278002)

Val Trp Phe Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C31H42N8O5 (606.3278002)

Val Trp Arg Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]-3-phenylpropanoic acid

C31H42N8O5 (606.3278002)

Val Tyr Tyr Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanoic acid

C32H38N4O8 (606.2689508)

Trp Phe Arg Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-5-carbamimidamidopentanamido]-3-methylbutanoic acid

C31H42N8O5 (606.3278002)

Trp Phe Val Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-methylbutanamido]-5-carbamimidamidopentanoic acid

C31H42N8O5 (606.3278002)

Trp His His Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

C29H38N10O5 (606.3026497999999)

Trp His Lys His

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]hexanamido]-3-(1H-imidazol-4-yl)propanoic acid

C29H38N10O5 (606.3026497999999)

Trp Lys His His

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]hexanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C29H38N10O5 (606.3026497999999)

Trp Arg Phe Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]-3-phenylpropanamido]-3-methylbutanoic acid

C31H42N8O5 (606.3278002)

Trp Arg Val Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]-3-methylbutanamido]-3-phenylpropanoic acid

C31H42N8O5 (606.3278002)

Trp Val Phe Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-methylbutanamido]-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C31H42N8O5 (606.3278002)

Trp Val Arg Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-methylbutanamido]-5-carbamimidamidopentanamido]-3-phenylpropanoic acid

C31H42N8O5 (606.3278002)

Tyr Ile Arg Arg

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-methylpentanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C27H46N10O6 (606.3601616000001)

Tyr Leu Arg Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-4-methylpentanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C27H46N10O6 (606.3601616000001)

Tyr Arg Ile Arg

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-5-carbamimidamidopentanamido]-3-methylpentanamido]-5-carbamimidamidopentanoic acid

C27H46N10O6 (606.3601616000001)

Tyr Arg Leu Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-5-carbamimidamidopentanamido]-4-methylpentanamido]-5-carbamimidamidopentanoic acid

C27H46N10O6 (606.3601616000001)

Tyr Arg Arg Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-methylpentanoic acid

C27H46N10O6 (606.3601616000001)

Tyr Arg Arg Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-4-methylpentanoic acid

C27H46N10O6 (606.3601616000001)

Tyr Val Tyr Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-methylbutanamido]-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanoic acid

C32H38N4O8 (606.2689508)

Tyr Tyr Val Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylbutanamido]-3-(4-hydroxyphenyl)propanoic acid

C32H38N4O8 (606.2689508)

Tyr Tyr Tyr Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylbutanoic acid

C32H38N4O8 (606.2689508)

FAEKI

Phe-Ala-Glu-Lys-Ile

C29H46N6O8 (606.3376956)

ECEVK

Glu Cys Glu Val Lys

C24H42N6O10S (606.2682992)

FQKKG

Phe-Gln-Lys-Lys-Gly

C28H46N8O7 (606.3489285999999)

YVGRL

Tyr-Val-Gly-Arg-Leu

C28H46N8O7 (606.3489285999999)

ESLMK

Glu Ser Leu Met Lys

C25H46N6O9S (606.3046826)

TKMVE

Thr Lys Met Val Glu

C25H46N6O9S (606.3046826)

Trandolapril glucuronide

C30H42N2O11 (606.2788462)

1,25-Dihydroxy-20S-21-(3-hydroxy-3-methylbutyl)-23-yne-26,27-hexafluorovitamin D3

(5Z,7E)-(1S,3R,20S)-21-(3-hydroxy-3-methyl-butyl)-23-yne-26,26,26,27,27,27-hexafluoro-9,10-seco-5,7,10(19)-cholestatrien-1,3,25-triol

C32H44F6O4 (606.3143616)

(5Z,7E)-(3S,23S)-24-oxo-9,10-seco-5,7,10(19)-cholestatriene-3,23,25-triol 23-D-glucuronide

(23S)-23,25-dihydroxy-24-oxovitamin D3 23-(β-glucuronide) / (23S)-23,25-dihydroxy-24-oxocholecalciferol 23-(β-glucuronide)

C33H50O10 (606.34038)

(23S)-23,25-dihydroxy-24-oxovitamin D3 23-(beta-glucuronide)

(5Z,7E)-(3S,23S)-24-oxo-9,10-seco-5,7,10(19)-Cholestatriene-3,23,25-triol 23-delta-glucuronide

C33H50O10 (606.34038)

OA-PA

1-(9Z-octadecenoyl)-2-azeloyl-sn-glycero-3-phosphate

C30H55O10P (606.353266)

OHODiA-PA

1-(9Z-octadecenoyl)-2-(5-hydroxy-7-carboxy-6E-heptenoyl)-sn-glycero-3-phosphate

C29H51O11P (606.3168826)

ST 27:3;O4;GlcA

(5Z,7E)-(3S,23S)-24-oxo-9,10-seco-5,7,10(19)-cholestatriene-3,23,25-triol 23-D-glucuronide

C33H50O10 (606.34038)

Pandaroside D

3beta-[beta-glucopyranosyloxyuronic acid]-16-hydroxy-5alpha,14beta-cholest-16-ene-15,23-dione

C33H50O10 (606.34038)

(1s,2s)-(+)-[1,2-cyclohexanediamino-n n-bis(3,5-di-t-butylsalicylidene)]aluminum (iii) chloride

C36H52AlClN2O2 (606.3532512)

Butyltin tris(2-ethylhexanoate)

C28H54O6Sn (606.2942174)

(1R,2R)-(-)-[1,2-Cyclohexanediamino-N,N-bis-(3,5-di-tert-butylsalicylidene)]aluminum(III)chloride

C36H52AlClN2O2 (606.3532512)

(R)-(-)-1-[(S)-2-Dicyclohexylphosphino)ferrocenyl]ethyldicyclohexylphosphine

C36H56FeP2 (606.3206426)

(S,S)-N,N-bis-(3,5-Di-tert-butylsalicylidene)-1,2-cyclohexanediaminoaluminum chloride

C36H52AlClN2O2 (606.3532512)

(s,s)-1-dicyclohexylphosphino-2-[1-(dicyclohexylphosphino)ethyl]ferrocene

C36H56FeP2 (606.3206426)

17-methoxy-10,12-dimethyl-18-(3,4,5-trimethoxy-benzoyloxy)-yohimbane-16-carboxylic acid methyl ester

C34H42N2O8 (606.2941012)

PHOOA-PE

C29H53NO10P- (606.3406908)

N,N-Diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine

2-[(2-{[2-({2-[bis(prop-2-en-1-yl)amino]-1-hydroxy-3-(4-hydroxyphenyl)propylidene}amino)-1-hydroxy-2-methylpropylidene]amino}-1-hydroxy-3-phenylpropylidene)amino]-4-methylpentanoate

C34H46N4O6 (606.3417176)

PA(8:0/5-iso PGF2VI)

C29H51O11P (606.3168826)

PA(5-iso PGF2VI/8:0)

C29H51O11P (606.3168826)

4-[2-(2-Benzyloxycarbonylamino-3-methyl-butyrylamino)-3-phenyl-propionylamino]-5-(2-oxo-pyrrolidin-3-yl)-pent-2-enoic acid, ethyl ester

C33H42N4O7 (606.3053342000001)

Dilazep hydrochloride

C31H46N2O10+2 (606.3152296)

Gemini-0072

C32H44F6O4 (606.3143616)

Gemini0097

C32H44F6O4 (606.3143616)

N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

C31H41F3N4O5 (606.3028892)

N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

C31H41F3N4O5 (606.3028892)

N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

C31H41F3N4O5 (606.3028892)

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

C31H41F3N4O5 (606.3028892)

N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

C31H41F3N4O5 (606.3028892)

N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

C31H41F3N4O5 (606.3028892)

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

C31H41F3N4O5 (606.3028892)

N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

C31H41F3N4O5 (606.3028892)

(7R,8S,9S,13S,14R,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol

C32H47F5O3S (606.3165892)

(2S)-2-[[(2S)-2-[[4-ethyl-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]oxycarbonylamino]-4-methylpentanoyl]amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid

C26H46N4O10S (606.2934496)

N-[5-[4-(3,6-diaminoacridin-10-ium-10-yl)butanoylamino]pentyl]-5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanamide

C32H44N7O3S+ (606.3226174)

2-Deacetoxytaxinine B

C35H42O9 (606.2828682)

(7R,8R,9R,13R,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol

C32H47F5O3S (606.3165892)

Smgdg O-16:4_3:0

C28H46O12S (606.2709836)

[1-acetyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C33H50O10 (606.34038)

[1-[(2-heptanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C30H55O10P (606.353266)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-octanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C30H55O10P (606.353266)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C30H55O10P (606.353266)

[1-[(2-butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

C30H55O10P (606.353266)

[1-[(2-acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

C30H55O10P (606.353266)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

C30H55O10P (606.353266)

[1-[(2-hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C30H55O10P (606.353266)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C30H55O10P (606.353266)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C30H55O10P (606.353266)

[1-butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

C30H55O10P (606.353266)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C30H55O10P (606.353266)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

C30H55O10P (606.353266)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C30H55O10P (606.353266)

[1-acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

C30H55O10P (606.353266)

[1-phosphonooxy-3-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate

C33H51O8P (606.3321376)

[1-phosphonooxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropan-2-yl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate

C33H51O8P (606.3321376)

13-Methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol

C32H47F5O3S (606.3165892)

(1S,4S,8S,9S,11R,13R,14R,16R)-7,9,13-trimethyl-6-[3-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]but-3-enyl]-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-6,18-diene-11,14,16-triol

C33H50O10 (606.34038)

DGMG 13:3

C28H46O14 (606.2887416)

SQMG 20:3

C29H50O11S (606.307367)

DGGA 21:0;O

C30H54O12 (606.3615084)

DGGA 23:6

C32H46O11 (606.3039966)

MGGA 24:6

C33H50O10 (606.34038)

PA O-16:0/11:3;O3

C30H55O10P (606.353266)

PA O-20:0/7:3;O3

C30H55O10P (606.353266)

PA O-27:3;O3

C30H55O10P (606.353266)

PA P-20:0/7:2;O3

C30H55O10P (606.353266)

PA 14:0/12:3;O3

C29H51O11P (606.3168826)

PA 14:1/12:2;O3

C29H51O11P (606.3168826)

PA 18:0/8:3;O3

C29H51O11P (606.3168826)

PA 18:1/8:2;O3

C29H51O11P (606.3168826)

PA 18:1/9:1;O2

C30H55O10P (606.353266)

PA 20:0/7:2;O2

C30H55O10P (606.353266)

PA 22:1/5:1;O2

C30H55O10P (606.353266)

PA 22:5/7:3;O

C32H47O9P (606.2957541999999)

PA 29:8;O

C32H47O9P (606.2957541999999)

LPGP 19:0

C25H52O12P2 (606.2933852)

LPGP O-20:0

C26H56O11P2 (606.3297686000001)

PG O-16:0/8:3;O

C30H55O10P (606.353266)

PG O-23:4;O2

C29H51O11P (606.3168826)

PG O-24:3;O

C30H55O10P (606.353266)

PG P-16:0/7:3;O2

C29H51O11P (606.3168826)

PG P-16:1/7:2;O2

C29H51O11P (606.3168826)

PG P-16:1/8:1;O

C30H55O10P (606.353266)

PG P-18:0/6:2;O

C30H55O10P (606.353266)

PG P-18:1/5:2;O2

C29H51O11P (606.3168826)

PG P-20:1/4:1;O

C30H55O10P (606.353266)

PG 14:1/8:3;O2

C28H47O12P (606.2804991999999)

PG 16:0/7:3;O

C29H51O11P (606.3168826)

PG 18:2/5:1;O

C29H51O11P (606.3168826)

PG 18:3/4:1;O2

C28H47O12P (606.2804991999999)

PG 22:4;O2

C28H47O12P (606.2804991999999)

PG 23:3;O

C29H51O11P (606.3168826)

PG 20:1/4:1

C30H55O10P (606.353266)

PG 2:0_22:2

C30H55O10P (606.353266)

PG 20:2/4:0

C30H55O10P (606.353266)

PG 22:2/2:0

C30H55O10P (606.353266)

PG 24:2

C30H55O10P (606.353266)

PEth 28:7

C33H51O8P (606.3321376)

PM 28:8;O

C32H47O9P (606.2957541999999)

PM 29:7

C33H51O8P (606.3321376)

ST 22:0;O8;GlcA

C28H46O14 (606.2887416)

ST 25:5;O6;GlcA

C31H42O12 (606.2676132)

ST 26:4;O5;GlcA

C32H46O11 (606.3039966)

ST 23:0;O8;Hex

C29H50O13 (606.3251250000001)

ST 25:6;O7;Hex

C31H42O12 (606.2676132)

ST 26:5;O6;Hex

C32H46O11 (606.3039966)

ST 27:4;O5;Hex

C33H50O10 (606.34038)

ST 29:1;O8;S

C29H50O11S (606.307367)

(1r,8r,10r)-2,9,10-tris(acetyloxy)-8,12,15,15-tetramethyl-4-methylidene-13-oxotricyclo[9.3.1.0³,⁸]pentadec-11-en-5-yl (2e)-3-phenylprop-2-enoate

C35H42O9 (606.2828682)

(3s,3ar,4s,6s,7s,8s)-6-(acetyloxy)-4-(butanoyloxy)-3,3a-dihydroxy-3,6,9-trimethyl-8-{[(2z)-2-methylbut-2-enoyl]oxy}-2-oxo-4h,5h,6ah,7h,8h,9bh-azuleno[4,5-b]furan-7-yl (2z)-2-methylbut-2-enoate

C31H42O12 (606.2676132)

(2r,3r,4s,5r,6r)-2-{[(2r,3r,4r,5s)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-4-[(3-methylbut-2-enoyl)oxy]oxan-3-yl dodecanoate

C29H50O13 (606.3251250000001)

(1r,3r,5s,7s,8s,9r,10r)-7,9,10-tris(acetyloxy)-8,12,15,15-tetramethyl-4-methylidene-13-oxotricyclo[9.3.1.0³,⁸]pentadec-11-en-5-yl (2e)-3-phenylprop-2-enoate

C35H42O9 (606.2828682)

(1r,3r,5r,6as,7r,8r,10s,10as)-1,3,5-tris(acetyloxy)-7,8-dimethyl-7-(3-methylidenepent-4-en-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl (2e)-3-phenylprop-2-enoate

C35H42O9 (606.2828682)

2,10,13-tris(acetyloxy)-8,12,15,15-tetramethyl-9-oxotricyclo[9.3.1.1⁴,⁸]hexadeca-3,11-dien-5-yl 3-phenylprop-2-enoate

C35H42O9 (606.2828682)

2-[8-(acetyloxy)-8a-[(acetyloxy)methyl]-5,6-dimethyl-4-[(2-methylpropanoyl)oxy]-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-5-yl]-1-(5-oxo-2h-furan-3-yl)ethyl 2-methylpropanoate

C32H46O11 (606.3039966)

(2r,3r)-2-[(1s,3as,5ar,7r,8s,9ar,9br,11ar)-7,8-bis(acetyloxy)-3a-hydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2,6-dihydroxy-6-methylheptan-3-yl acetate

(2r,3r)-2-[(1s,3as,5ar,7r,8s,9ar,9br,11ar)-7,8-bis(acetyloxy)-3a-hydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2,6-dihydroxy-6-methylheptan-3-yl acetate

C33H50O10 (606.34038)

(1s,2s,3ar,5r,10r,11s,13r,13ar)-3a,11,13-tris(acetyloxy)-2,5,8,8-tetramethyl-12-methylidene-10-(2-methylpropoxy)-4,9-dioxo-1h,2h,3h,5h,10h,11h,13h,13ah-cyclopenta[12]annulen-1-yl acetate

C32H46O11 (606.3039966)

(2s,3as,6r,7as)-n-(1-carbamimidoylpyrrolidin-2-yl)-1-[(2r)-2-{[(2r)-3-(3-chloro-4-hydroxyphenyl)-1,2-dihydroxypropylidene]amino}-4-methylpentanoyl]-6-hydroxy-octahydroindole-2-carboximidic acid

C29H43ClN6O6 (606.2932448)

(1s,3s,5s,6ar,7s,8s,10r,10ar)-1,3,5-tris(acetyloxy)-7,8-dimethyl-7-[(2e)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl (2e)-3-phenylprop-2-enoate

C35H42O9 (606.2828682)

methyl 16-ethenyl-11-ethyl-22-(3-methoxy-3-oxopropyl)-12,17,21,26-tetramethyl-4-oxo-7,23,24,25-tetraazahexacyclo[18.2.1.1⁵,⁸.1¹⁰,¹³.1¹⁵,¹⁸.0²,⁶]hexacosa-1(23),2(6),5(26),7,9,11,13,15,17,19-decaene-3-carboxylate

methyl 16-ethenyl-11-ethyl-22-(3-methoxy-3-oxopropyl)-12,17,21,26-tetramethyl-4-oxo-7,23,24,25-tetraazahexacyclo[18.2.1.1⁵,⁸.1¹⁰,¹³.1¹⁵,¹⁸.0²,⁶]hexacosa-1(23),2(6),5(26),7,9,11,13,15,17,19-decaene-3-carboxylate

C36H38N4O5 (606.2842058)

2-(hydroxymethyl)-6-{7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-15',16'-dioloxy}oxane-3,4,5-triol

C33H50O10 (606.34038)

17-(acetyloxy)-8-(furan-3-yl)-4,19-dihydroxy-1,9,11,16-tetramethyl-5,14-dioxapentacyclo[11.6.1.0²,¹¹.0⁶,¹⁰.0¹⁶,²⁰]icos-9-en-12-yl benzoate

C35H42O9 (606.2828682)